Summary
IgA, the predominant isotype in secretions, mediates the neutralization and removal ofenvironmental antigens from mucosal sites . Although cell surface receptors for the Fc region of IgA (FcaR) have been implicated in a variety ofimmune effector mechanisms, the molecular features ofFcaR remain only marginally characterized. In this report, we describe the isolation of a clone from a myeloid cell line cDNA library that directs the expression of a cell surface molecule with IgA binding specificity. The cDNA encodes a peptide of Mr 30,000 including a putative transmembrane region with features atypical ofconventional membrane-anchored proteins. Databank searches indicate that the human myeloid cell FcaR sequence is unique, is a member of the immunoglobulin gene superfamily, and is related to Fc receptors for IgG (FcyRI, II, and III) and IgE (Fcc-RI) .
Cells. The monocyte-like cell line U937 (15) was maintained in continuous culture in RPMI 1640 supplemented with 10% FCS. Differentiation was induced by culturing the cells overnight in the presence of 5 ng/ml ofPMA (Sigma Chemical Co., St. Louis, MO).
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Monocytes and polymorphonuclear leukocytes were purified from heparinized peripheral blood by centrifugation through isolymph (Gallard-Schlesinger Chemical Mfg. Corp., Carle Place, NY), followed by centrifugal elutriation, using a centrifuge (6 M/E; Beckman Instruments, Inc., Fullerton, CA) equipped with a JE-5.0 rotor. The resulting fractions were analyzed by Wright-Giemsa staining of cytocentrifuge preparations.
Human T lymphocytes were purified from tonsils by E-rosetting with 2-aminoethylisothio-uronium bromide (AET)'-treated SRBC, followed by Ficoll-Hypaque density gradient centrifugation (16) . Tonsillar B lymphocytes were isolated from the leukocyte layer resulting from AETSRBC and Ficoll separation, with further depletion ofnon-B cells achieved by treatment with antibody and complement using Lympho-Kwik B (One Lambda, Los Angeles, CA) . Purified preparations ofT and B cells were maintained in a medium consisting ofRPMI 1640/10% FCS (HyClone Laboratories, Logan, UT), sodium pyruvate (1 mM), nonessential amino acids (100 mM), penicillin/streptomycin (100 U/ml per 100 Etg/ml), L-glutamine (2 mM), 2-ME (50 mM), and fungizone (1:2,000 ; Gibco Laboratories, Grand Island, NY). B cells or T cells were cultured either alone or, as indicated, in the presence of Con A (20 lzg/ml; Sigma Chemical Co.), PWM (40 ug/ml; Sigma Chemical Co.), or PMA (5 ng/ml) plus ionomycin (500 ng/ml; Calbiochem-Behring Corp., San Diego, CA) . After a 16-h incubation, cells were harvested for RNA preparation as described below.
cDNA Expression and Immunoselection. cDNA was synthesized from polyadenylated RNA extracted from 12-h PMA-stimulated U937 cells according to standard protocols (17) . The cDNA was 'Abbreviations used in this paper: AET, 2-aminoethylisothio-uronium bromide; GPI, glycosyl-phosphatidyl inositol; OE, ox erythrocyte; PLC, phospholipase C. ligated into pDC303, a modified version ofthe pDC302 mammalian expression plasmid (18) , using nonselfcomplementary linkers containing Bg1II restriction sites.
The cDNA library representing 600,000 independent clones was amplified by growing bacteria in liquid cultures in the presence of chloramphenicol overnight, then plating at a density of 5,000 colonies per plate. Colonies were scraped from plates and pooled, and plasmid DNA was recovered and purified by alkaline lysis and CsCl gradient centrifugation (19) . Plasmid DNA from the cDNA library was used to transfect a subconfluent layer ofmonkey COS-7 cells using DEAF dextran followed by chloroquine treatment, as described (20) . FCaR`cells were selected by incubation in the My43 anti-FcciR mAb (14) , followed by panning on anti-IgMcoated plates according to established procedures (21) . Episomal DNA was prepared from the panned cells, amplified, and reintroduced into COS cells. After three such rounds of transfection (two DEAE dextran rounds and one protoplast fusion round) and immunoselection, 96 individual plasmid-transformed bacterial colonies were grown, collected into 20 pools, and pooledplasmids were extracted by alkaline lysis (19) and transfected into COS cells. Positive pools were selected by flow cytometric analysis of anti-FCaR (My43) binding to transfected cells. Individual clones containing FcotR cDNA were isolated from positive pools. One of these, pHuFcciR, was selected for characterization .
Sequence Analysis. DNA sequencing was performed on both strands as previously described (22) . For alignment analysis, residues constituting the two extracellular Ig domains were aligned with other FcR Ig domains using computerized models (NBRF program ALIGN [23] ) and by eye . The MD data matrix was used with a bias of +6, and a gap penalty of 6 was used. Scores are the SD for the indicated pair of aligned sequences vs. the average scores from 100 randomized alignments of the same pair of sequences .
Immunoglobulins. The My43 anti-FcaR murine hybridoma cell line (IgM, u) was maintained in Dulbecco's medium containing 10% FCS. Supernatants were collected at twice-weekly intervals, sterile filtered, and stored at 4°C. Human IgAl and IgGI paraproteins were purified as previously described (14) . F(ay)2 anti-ox erythrocytes (OE) was prepared from rabbit anti-OE IgG (CooperBiomedical, Inc ., Malvern, PA) by pepsin cleavage and passage through protein A-Sepharose CL-6B.
Flow Cytometry. For anti-FcaR binding experiments, cells were incubated with hybridoma culture supernatants containing either My43 mAb or a nonspecific isotype control mAb. After 30 min at 4°C, cells werewashed and incubated with fluoresceinated second antibody (affinity-purified goat anti-murine IgM, It chain specific [F(ab')2]) for 30 min at 4°C, then washed. For IgA binding experiments, cells were stained with 12.5 Wg/ml FITC-conjugated human myeloma IgAl or IgGI (30 min at 4°C). All antibody dilutions and washes were performed in PBS/0 .1% BSA/0.05% sodium azide. Cells were analyzed on a FACScan flow cytometer using a logarithmic fluorescence intensity scale.
Rosette Assay. Conjugates ofIgA or IgG linked to anti-OE were made by using the bifunctional reagent SPDP (Pharmacia Fine Chemicals, Uppsala, Sweden) (24) . IgA or IgG and F(ab'h anti-OE (at 1-3 mg/ml) were treated separately with an eightfold molar excess of SPDP for 2 h at 18°C. SPDP-treated anti-OE F(ab')2 was dialyzed in PBS, pH 7.2, and SPDP-treated IgA and IgG were dialyzed in 0.1 M acetate, 0.1 M NaCl, pH 4.5, treated with 0.02 M dithiothreitol (30 min), and passed through a G25 Sephadex column (Pharmacia Fine Chemicals), equilibrated in 0.1 M phosphate, 0.1 M NaCl, pH 7.5. Equimolar amounts of the anti-OE F(ab')2 and I&A orIgG were then mixed and incubated at 18°C for 4 h, after which crosslinking was terminated with 2 mM iodoacetamide . Preparations contained <15% noncrosslinked Ig.
1666 Expression Cloning of a Human Fc Receptor for IgA Packed OE (10 pl) were mixed for 16 h at 10°C with 25 Al of the F(ab')2 conjugates at concentrations previously determined to give maximal rosette formation. Equal volumes ofcells (transfected COS-7 or U937 cells) at 2 x 106/ml and a 1% suspension of heteroantibody-coated OE were centrifuged together and incubated on ice for 90 min. In some cases, cells were preincubated on ice with human IgA, IgG, My43, or control IgM mAb before the addition ofOE. After gentle resuspension, the percentage ofrosetteforming cells, defined as cells binding greater than four OE, was determinedby counting a minimum of 200 cells in duplicate samples using light microscopy.
Hybridization Techniques. Total RNA was isolated from cells as described (25) , then subjected to oligo(dT)-cellulose chromatography to purify polyadenylated RNA (19) . The mRNA was subjected to electrophoresis in a fonnaldehyde/1 .2% agarose gel, blotted by capillary flow onto a Nytran filter (Schleicher & Schnell, Inc ., Keene, NH) (26) , and hybridized for 16 h at 63°C in Starks hybridization solution (50% formamide, 2x Denhardt's solution, 5x SSC, 0.1% SDS, 50 mM KH2P04, 20 mM EDTA, 0.05% N-lauroylsarcosine,150 dug sheared, denatured salmon sperm DNA per ml) containing 'ZP-labeled antisense riboprobe transcribed from the 5' portion (-430 bases) of pHuPcak . Washes were carried out in 2x SSC, 0.1% SDS at 63°C. Dried filters were exposed to Kodak X-Omat AR film for 2 d and developed.
Human placental genomic DNA was isolated as described (27) and digested to completion with the indicated restriction endonucleases. 8 Ag of digested DNA was subjected to electrophoresis on a 0.7% agarose gel, transferred to a Nytran filter, and hybridized for 16 h at 42°C in Starks solution containing a '2P-labeled 700-bp fragment encoding the 5' untranslated and extracellular coding region of FcaR. Hybridized blots were washed in 0.2x SSC, 0.1% SDS at 65°C, dried, and autoradiographed.
Results and Discussion
The My43 mouse mAb binds selectively to a cell surface receptor for IgA on human myeloid cells . We used this mAb as the basis for immunoselection of an FcaR cDNA clone, using a modification of the technique previously described by Seed and Aruffo (21) . The U937 cell line represented a convenient source ofmRNA for cDNA library construction, since FcaR expression as measured by My43 binding is inducible by PMA treatment . We found that maximal FcaR cell surface expression occurred after 24 h in the presence of PMA, suggesting that maximal mRNA levels are achieved at an earlier time point . Thus, polyadenylated RNA was extracted from U937 cells treated for 12 h with PMA, and a cDNA library was prepared in the pDC303 mammalian expression plasmid.
Purified plasmid DNA from the U937 cDNA library was transfected into COS-7 cells, FcaRexpressing cells were isolated by panning with the My43 mAb, and plasmid DNA was extracted from the immunoselected COS-7 cells. After additional rounds of transfection and immunoselection, an individual FcaR cDNA done was selected by flow cytometric analysis of transfected COS cells using the My43 mAb. As shown in Fig . 1 A, My43 bound to a subpopulation of COS cells transfected with pHuFmR, but failed to react with cells transfeected with an insertless p12smid. An isotype control mAb displayed onlybackground binding with both cell types (Fig.  1 B) . Besides expressing a cell surface epitope recognized by My43, these cells were also capable of binding IgA. Thus, FcaR transfected COS cells directly bound FITC-conjugated human IgA (Fig. 1 C) , but not human IgG-FITC (Fig. 1  D) . In contrast, control COS cells displayed only background binding of either Ig isotype. The receptor exhibited the expected binding specificity, since IgAFITC binding was inhibited by unconjugated human IgA and by My43, but not by human IgG or an irrelevant murine IgM mAb (not shown) .
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FcR* COS cells were treated for 30 min at 4°C with hybridoma supernatants or purified Ig, or with medium alone. The cells were then examined for ability to form rosettes with OE coated with human myeloma IgA, as described in Materials and Methods. Results show mean and SD of duplicates .
FcaiR expression was also measured by the ability of transfected cells to form rosettes with IgA-coated OE (Fig. 2) . COS cells transfected with pHuFcctR formed distinct rosettes when incubated in the presence of human IgA-coated Fig. 2 A) , whereas control COS cells did not (Fig. 2  F) . This activity was completely inhibited by the My43 mAb (Fig. 2 B) and human IgA (Fig. 2 C) , but not by human IgG (Fig. 2 D) . In a separate experiment, the inhibitory effects of My43 and human IgA were found to be dose dependent ( The structural features of the 1.6-kb cDNA insert in pHuFccfR were determined by restriction endonuclease mapping (Fig. 3 A) and nucleotide sequence analysis (Fig. 3 B) . The pHuFcciR cDNA is composed of a 39-bp 5' untranslated region, a 861-bp open reading frame, and a 711-bp 3' untranslated region terminating in a poly-A tract. The 3' region also includes an Alu-sequence (1020-1296) (reference When the amino acid sequence for the extracellular region was compared with existing protein sequence databases using the FASTA algorithm (30), homology was found with the other Ig Fcks sequenced to date. Further analysis of the FcR sequences using the NBRF program ALIGN (23) revealed statistically significant alignments between the FcciR and other members of this receptor family. Most notably, the FcceR appeared, as do the other FcRs, to contain several conserved residues that are the hallmarks ofIg-like sequences (31) in two contiguous domains. These residues, including the two cysteines in each domain that form the disulfide bond that holds together the Ig fold (31) , are indicated in an alignScores are the SD for the indicated pair of aligned sequences (top) vs . the average scores from 100 randomized alignments of the same pair of sequences (bottom) . Fig . 4 ). The resulting ALIGN scores from the alignment are shown in Table 2 . It is clear from these alignments that although the FcaR is homologous to the other known FcRs and is more closely related to those proteins than to several other members of the Ig superfamily, it is somewhat more distantly related to other FcRs than are these receptors to each other. Thus, it is likely that the FcciR diverged from a common ancestor very early in the development of the Ig FcR gene family. The existence of a distinct family of FcRs is supported by previous work demonstrating that the genes for FcyRI, FcyRII, FcyRIII, and the a chain of FceRI map to the long arm of chromosome 1 (32, 33) . We are currently investigating the possibility that the FCaR, which shares structural and functional qualities with these other FcRs, maps to the same chromosomal region . Hydropathicity analysis indicated that the extracellular region of the FcaR is followed by a 19-residue stretch of hydrophobic amino acids (Leu 207 to Val 225) corresponding to a potential transmembrane region . The intracytoplasmic region would thus be composed of41 amino acids. Two features of the putative transmembrane region are atypical of "protein anchored" transmembrane proteins, including the presence of a charged residue (Arg 230) within the hydrophobic transmembrane domain and the lack of a cluster of basic residues immediately following the hydrophobic stretch (34) . A number of proteins containing a charged residue in the transmembrane region have been reported to attach to the membrane either through a glycosyl-phosphatidyl inositol (GPI) linkage (e.g., the Qa-2 MHC antigen ; reference 35) or by association with another membrane-bound protein (e .g., the TCR, which requires association with the CD3 complex for cell surface expression ; reference 36) . With regard to Fc receptors, the a chain of the high affinity IgE receptor (FceRI) contains an Asp residue in the transmembrane region and is attached by the latter mechanism, i.e., through interaction with the y chain (37) . The two genes for human FcyRIII also include an Asp residue in the middle of the membrane-spanning region (38) . The FcyRIII isoform expressed by PMNs is GPI linked (38, 39) , while the isoform expressed by NK cells and macrophages appears to require an additional peptide for cell surface expression, a function that can be provided by the y chain of the FteRI (40, 41) . The critical difference between these two isoforms appears to reside in the presence or absence of a Ser 203 residue in the extracellular region, which signals GPI attachment (40) (41) (42) . Although there is a Ser residue in an analogous site of the FcciR (Ser 197), it is unlikely that FcoiR is GPI linked, since Monteiro et al. (13) have shown that FcciR on human monocytes, granulocytes, and U937 cells are resistant to cleavage with GPI-specific phospholipase C (PLC). We have made similar observations with these cell populations, and also found that the level of expression ofFcciR on transfected COS cells was unaffected by PLC treatment . The presence of an associated protein cannot be ruled out, although results with transfected COS cells would require such a protein to be present in both myeloid cells and COS-7 cells . Clearly, additional studies are required to determine the nature of FcaR attachment and the possible relevance of the different forms of membrane attachment of Fc receptor function.
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Using an RNA probe representing the 5' untranslated region and coding sequence for a portion of the extracellular region, we analyzed expression of FcctR mRNA (Fig. 5) . Two major hybridizing transcripts of -2.8 and -2.6 kb were observed in polyadenylated RNA preparations from U937 cells, peripheral blood monocytes, and PMN. PMA stimulated References U937 cells expressed significantly higher FcoIR message levels in comparison with unstimulated U937 cells, which is consistent with the finding that U937 cell surface FcctR protein expression is PMA inducible (13) . Subpopulations ofhuman B and T lymphocytes have been reported to express cell surface FcotR (43--45) . Except for nonspecific binding to ribosomal RNA, the FcotR probe failed to hybridize with polyadenylated RNA from either untreated or mitogen-stimulated tonsillar B or T cells (Fig. 5, lanes 5-9) , even after extended exposure ofblots. This finding would suggest either that the receptor on these cells is structurally distinct or that the conditions used failed to induce receptor expression.
Human genomic DNA was digested with five different restriction endonucleases and subjected to Southern blot analysis, using as probe a 12P-labeled cDNA fragment representing the 5' untranslated and extracellular regions of the Fcak cDNA (Fig. 6) . Single or double hybridizing bands were observed for each restriction digest, suggesting that the human myeloid FcotR gene exists as a single copy.
In conclusion, we have isolated a cDNA clone encoding a cell surface protein that displays IgA binding properties and that is structurally similar to FcRs for other isotypes. The availability of this cDNA will facilitate investigations into such issues as genomic organization, regulation of gene expression, and structure/function relationships . Furthermore, a plasmid that directs the synthesis of recombinant soluble FcciR was recently constructed (Maliszewski, C., unpublished results). Clearly, such a reagent will be valuable in dissecting the role of Fcak in IgA-mediated effector functions and in immunoregulation of IgA synthesis.
